Loss of gene function is a valuable tool for screening genes in cellular processes including stem cell differentiation differentiation. However, the criteria for evaluating gene knockdown are usually based on end-point analysis and real-time, dynamic information is lacking. To overcome these limitations, we engineered a shRNA encoding LentiViral Dual Promoter vector (shLVDP) that enabled real-time monitoring of mesenchymal stem (MSC) differentiation and simultaneous gene knockdown. In this vector, the activity of the alpha-smooth muscle actin (aSMA) promoter was measured by the expression of a destabilized green fluorescent protein, and was used as an indicator of myogenic differentiation; constitutive expression of discosoma red fluorescent protein was used to measure transduction efficiency and to normalize aSMA promoter activity; and shRNA was encoded by a doxycycline (Dox)-regulatable H1 promoter. Importantly, the normalized promoter activity was independent of lentivirus titer allowing quantitative assessment of gene knockdown. Using this vector, we evaluated 11 genes in the TGF-b1 or Rho signaling pathway on SMC maturation and on MSC differentiation along the myogenic lineage. As expected, knockdown of genes such as Smad2/3 or RhoA inhibited myogenic differentiation, while knocking down the myogenic differentiation inhibitor, Klf4, increased aSMA promoter activity significantly. Notably, some genes for example, Smad7 or KLF4 showed differential regulation of myogenic differentiation in MSC from different anatomic locations such as bone marrow and hair follicles. Finally, Dox-regulatable shRNA expression enabled temporal control of gene knockdown and provided dynamic information on the effect of different genes on myogenic phenotype. Our data suggests that shLVDP may be ideal for development of lentiviral microarrays to decipher gene regulatory networks of complex biological processes such as stem cell differentiation or reprogramming.
INTRODUCTION
Since its discovery, RNAi has become a powerful tool for understanding gene function through loss-of-function screening. For example, gene silencing was used to identify tumorsuppressor genes, 1 genes essential for maintaining stemness 2 or controlling cell differentiation. 3, 4 In addition to understanding biological processes, RNAi has been proposed as a novel strategy for cancer therapy, antiviral therapy, treatment of genetic or metabolic disorders as well as cell reprogramming for personalized regenerative medicine. 5 In addition to single gene knockdown, investigators developed RNAi libraries to discover gene pathways controlling various cellular processes and facilitate global understanding of cellular behavior. 6 --9 This approach was used to identify genes that are involved in proteasome-mediated proteolysis, 10 virus infection and replication, 11 --14 cytokinesis, 8, 9, 15, 16 endocytosis, 17 stem cell self-renewal 18 or cancer cell proliferation and survival. 19, 20 RNAi knockdown requires a good selection strategy to link genetic information to cellular phenotype. In many cases, such readout is based on cell proliferation or expression of marker proteins that are detected by antibody staining in order to score a 'hit'. These procedures are usually destructive and therefore, they are employed as end-point analyses. In addition, quantitative comparison among samples suffers from differences in gene transfer efficiency owing to differences in the titer of viral preparations. To overcome these limitations, we engineered a shRNA encoding LentiViral Dual Promoter (shLVDP) vector that contains three transcriptional units. The first encodes for unstable ZsGreen (ZsG-DR) under a promoter of interest and is used as readout to monitor the effect of gene knockdown on cellular phenotype. The second encodes for discosoma red fluorescent protein (DsRed)-Express under a constitutive promoter for example, human phosphoglycerate kinase promoter (hPGK) and is used to assess gene transfer efficiency as well as for data normalization to obtain quantitative data independent of the gene transfer efficiency. 21, 22 Finally, the third unit encodes for shRNA under a tetracycline-regulatable H1 promoter in the viral LTR. This vector allows shRNA expression and at the same time provides quantitative real-time monitoring of the effect of gene knockdown on cellular phenotype.
Using the shLVDP vector, we measured the effects of several genes in the TGF-b1 and Rho pathways on maturation of human aortic smooth muscle cells (HASMC) and in myogenic differentiation of mesenchymal stem cells from bone marrow (BM-MSCs) and hair follicles (HF-MSC). TGF-b1 has been shown to upregulate the expression of alpha-smooth muscle actin (aSMA) in SMC 23 and MSC, 24, 25 and RhoA is known to affect actin reorganization and contractile activity. 26 Myogenic differentiation was monitored by the aSMA promoter activity and confirmed by western blot and immunostaining. Normalized promoter activity rendered the results independent of gene transfer efficiency and allowed comparison of the relative effect of each gene on myogenic differentiation of different cell types. Finally, Dox-inducible shRNA expression enabled temporal control of gene knockdown and prevented toxic effects associated with loss of genes that are important in cell spreading or cytoskeletal reorganization.
RESULTS

Generation of shLVDP vector
Recently, our laboratory developed a LVDP that provides a high expression level of two genes from independent promoters in mammalian cells including MSCs. 22 A constitutive promoter drives expression of one marker gene (for example, DsRed) and is used to measure transduction efficiency. The promoter of interest drives expression of another marker (for example, green fluorescent protein (EGFP)) and is used to monitor the biological process of interest. Polyadenylation, terminator and insulator sequences were inserted between the two transcription units to eliminate promoter interference yielding promoter activity that was similar to that exhibited by vectors containing a single transcription unit. This vector was used to generate lentiviral microarrays to monitor the dynamics of gene expression in real time in response to external stimuli. 21 In this study, we modified this vector to also express shRNA from a tetracycline-regulatable H1 promoter, thereby allowing assessment of genes that may be involved in a process, which can be monitored in real time by the activity of a promoter or response element (RE) (Figure 1a ). To this end, the 3 0 LTR of our LVDP vector was substituted by the 3 0 LTR of pLVTHM vector, which was engineered to express shRNA under a tetracyclineregulatable H1 promoter. 27, 28 During reverse transcription of the lentiviral RNA, the 3 0 LTR replaces the 5 0 LTR, thereby allowing expression of two shRNA copies for each integrated lentivirus genome. Overall, this modified vector expresses two genes and one shRNA and was termed shLVDP.
Signal normalization shows that promoter activity is independent of lentivirus titer The shLVDP allows measurement of promoter activity through changes in green fluorescent intensity (GFI), which depends on the number of infected cells and the number of transgene copies per cell. However, quantitative measurements of promoter activity may suffer by lack of consistency due to differences in gene transfer efficiency among different lentivirus preparations each expressing a different shRNA. As shLVDP also encodes for DsRed under a constitutive promoter we hypothesized that normalization of GFI by the red fluorescence intensity (RFI) may be independent of the gene transfer efficiency, thereby yielding quantitative data.
To address this hypothesis, we employed shLVDP encoding for EGFP under the hPGK promoter, DsRed under the cytomegalovirus promoter (CMV) promoter and scramble shRNA under the H1 promoter to transduce HASMCs with two MOI that differed by 10-fold, MOI ¼ 1 and MOI ¼ 10. As expected, RFI and GFI increased with increasing virus concentration as measured by fluorescence microscopy (Figures 1b and c) or flow cytometry (Figures 1e and f) , likely due to increased fraction of transduced cells and/or increased number of gene copies per cell. However, the normalized fluorescence intensity (GFI/RFI) remained the same regardless of the analysis method (Figures 1d and g ), suggesting that the intrinsic promoter activity was independent of virus titer. This result suggests that internal signaling normalization can be used to eliminate disparity owing to differences in transduction efficiency, thereby enabling acquisition of quantitative data. shLVDP can be used to monitor smooth muscle cell maturation Next, we modified this vector to enable monitoring of gene expression from any promoter or RE. As REs usually require addition of a minimal CMV promoter to achieve high expression levels, we substituted the CMV promoter-driving DsRed with the hPGK promoter to avoid the potential of homologous recombination due to repeated sequences, as previously reported for lentiviral vectors. 29 We also replaced EGFP with ZsG-DR, a brighter and destabilized (t 1/2 ¼ 8 --12 h) green fluorescent protein to better capture the kinetics of gene expression. Finally, we cloned the promoter for the well-known early myogenic marker, aSMA upstream of ZsG-DR, to monitor smooth muscle cell maturation in response to TGF-b1 treatment. The resulting vector (Figure 2a ) was used to produce recombinant lentivirus to transduce HASMCs. Three days after transduction, the cells were cultured either in growth medium (GM:SMGS) or differentiation medium (DM: SMDS þ 10 ng ml --1 TGF-b1) in the presence or absence of TGF-b1 receptor inhibitor, SB431542 (SB4). Fluorescence intensity was measured 3 days later using fluorescence microscopy and flow cytometry.
Under growth conditions, cells displayed basal aSMA promoter activity (normalized intensity, NI ¼ 0.94), which increased by 3-fold (NI ¼ 2.8) in the presence of TGF-b1 (Figure 2b) . Addition of the TGF-b1 inhibitor, SB431542, significantly reduced the aSMA promoter activity by 16-fold (NI ¼ 0.17). Similarly, flow cytometry showed that the normalized intensity (GFI/RFI) increased by 2.5-fold (NI ¼ 2.45) upon treatment with TGF-b1, whereas addition of the TGF-b1 receptor inhibitor, SB431542, reduced GFI/RFI by 18-fold (NI ¼ 0.05) (Figure 2c ). In addition to the normalized intensity, the percentage of ZsG-DR þ cells was 3.3 ± 0.78, 26.1±1.56 or 0.17±0.06% in GM, DM or DM þ SB431542, respectively (Figure 2d ). In agreement, western blot showed that aSMA protein level increased by 3.35 ± 0.3-fold in DM (Figure 2e ), which was further verified by immunostaining (Figure 2f ). In particular, under GM aSMA expression was weak and diffuse but upon TGF-b1 treatment, aSMA was organized in filaments--an indication of contractile myogenic phenotype (Figure 2g ). Taken together, these results suggested that our shLVDP can be used to monitor TGF-b1-mediated myogenic differentiation.
Normalized promoter activity is independent of the extent of gene silencing The ability to monitor cell differentiation using our lentiviral vector suggested that this system could be used to examine the effects of various genes/pathways in myogenesis using shRNA knockdown from the same vector as shown in Figure 3a . As the extent of gene silencing may vary with the transduction efficiency, we examined whether differential shRNA expression might affect the level of promoter activity.
To address this issue, we expressed shRNAs-representing genes that are known to affect myogenic differentiation (Klf4 and Smad4) from the H1 promoter of the shLVDP vector shown in Figure 3a . The same vector also encodes for ZsG-DR under the aSMA promoter and DsRed under the hPGK promoter. As expected, higher virus titer resulted in higher knockdown of the Klf4 or Smad4 genes as shown by the decreased mRNA levels ( Figure 3b ). To evaluate promoter activity upon gene silencing, HASMC were transduced with the shLVDP at the indicated virus MOI and cultured in the presence of TGF-b1 to induce myogenic differentiation. Three days later, aSMA promoter activity was determined by fluorescence microscopy.
As expected, higher virus concentrations resulted in higher transduction efficiency as indicated by higher RFI values ( Figure 3c) . Similarly, the level of GFI---an indicator of aSMA promoter activity---depended strongly on the transduction efficiency ( Figure 3d ). Specifically, for scramble shRNA that did not affect aSMA promoter activity, GFI increased with increasing lentivirus concentration. Knockdown of the myogenic inhibitor, Klf4 also enhanced GFI, whereas knockdown of pro-myogenic genes, for example, RhoA or Smad4 decreased GFI in a lentivirus concentration-dependent manner. In contrast to GFI, the normalized aSMA promoter activity (GFI/RFI) was independent of the lentivirus concentration for the range of MOI tested (Figure 3e ), strongly suggesting that the normalized promoter activity was independent of the extent of gene silencing.
Evaluating gene knockdown on TGF-b1-induced aSMA promoter activity We used TGF-b1 to induce SMC maturation as a model system to demonstrate the utility of the shLVDP vector in measuring promoter activity with simultaneous gene silencing. To this end, we employed the shLVDP vector encoding ZsG-DR under the aSMA promoter, DsRed under the PGK promoter and shRNA under the H1 promoter targeting the indicated genes. The genes that were selected for knockdown are known effectors of TGF-b1 signaling including Smad2, Smad3, Smad4 and Smad7; the RhoA pathway such as RhoA, Rock1, Mrtf-B/Mlk2, Pkn1; as well as other transcription factors that are known to be important in myogenic differentiation such as Srf, Klf4 and MyoCD. The knockdown efficiency of each shRNA sequence was first measured by real time-PCR in transiently transfected 293T cells and only shRNAs showing at least 60% knockdown were chosen for further experiments (Supplementary Figure S1 ; Supplementary Material).
Next, HASMC were transduced with shLVDP each encoding for the indicated shRNA (Figure 4a ). Three days later, modified cells were coaxed into a mature SMC phenotype by switching to DM and aSMA activity was measured using a Zeiss Observer.Z1 microscope (Carl Zeiss Inc., Thornwood, NY, USA) equipped with environmental room with temperature, CO 2 and humidity control. Image analysis was performed using the Cell Profiler software (see Methods section) and GFI was normalized to RFI to report promoter activity independent of gene transfer efficiency.
As shown in Figure 4b , silencing myogenic transcription factors (Srf, MyoCD), TGF-b or Rho pathway effectors (for example, Smad2, Smad3, Smad4, RhoA, Rock1, Mrtf-B/Mlk2, Pkn1) decreased aSMA promoter activity significantly as compared with control (scramble shRNA in DM). On the other hand, knocking down the myogenic differentiation inhibitor Klf4 increased aSMA promoter activity significantly by almost 2-fold. These measurements were verified by flow cytometry that showed a significant 3.40 ± 0.41-fold increase in the fraction of ZsG-DR þ cells upon Klf4 knockdown (Figure 4c ).
In addition, immunostaining showed that aSMA promoter activity correlated with aSMA protein intensity and organization ( Figure 5 ). Specifically, HASMC transduced by scramble or Klf4-shRNA spread more and expressed higher level of aSMA, which was also organized in filaments, indicating mature myogenic phenotype. In contrast, RhoA knockdown induced cell rounding and abolished aSMA protein expression in agreement with the decline in aSMA promoter activity. Finally, cells that were modified with Smad4 shRNA became elongated with diffused aSMA staining and no filamentous organization. Taken together, these results demonstrate that the effect of shRNA on aSMA promoter activity correlated with protein expression and fibrous organization.
shLVDP for monitoring MSC differentiation to the myogenic lineage To demonstrate the application of this approach in stem cell differentiation, we employed BM-MSCs and HF-MSC. The cells were transduced with the same group of lentiviruses, coaxed to differentiate into SMC in DM and 3 days later GFI and RFI were measured by fluorescence microscopy. Similar to HASMC, aSMA promoter activity decreased significantly by knocking down TGF-b1 or Rho pathway effectors and increased by knocking down Klf4 (Figures 6a and b) . Interestingly, although knocking down Klf4 increased aSMA activity (GFI/RFI) in HASMC (1.68 ± 0.07; Po0.05) and BM-MSC (2.03 ± 0.42; Po0.05), it had no effect on HF-MSC (1.35±0.19; P40.05). On the other hand, Smad7 knockdown had a small effect on HASMC but decreased aSMA activity in BM-MSC (0.722 ± 0.06; P ¼ 0.065) and to a much larger extent in HF-MSC (0.11 ± 0.03; Po0.05). These results suggest that Klf4 and Smad7 may differentially regulate aSMA expression in HF-MSC compared with BM-MSC and HASMC. We also verified MSC differentiation into the SMC lineage using a gel compaction assay, an indicator of force generation ability, the quintessential property of SMC. To this end, HF-MSCs or BM-MCS were induced to differentiate into SMC in DM and then embedded into fibrin hydrogels (10 6 cells ml --1 ). After polymerization was complete (1 h), the gels were released from the wells and allowed to contract. At 48 h, the gels were photographed and the gel area was measured using Image J software. As shown in Supplementary Figure S2A , HF-MSCs compacted the hydrogels by B70% in DM but only by B20% in GM and compaction was diminished in the presence of SB431542. Similar results were observed with BM-MSCs (Supplementary Figure S2B ). In agreement with aSMA activity, this data suggested that treatment with DM-induced HF-MSC and BM-MSC differentiation into contractile SMCs.
Dox-inducible shRNA expression during MSC differentiation
To study MSC differentiation with regulated shRNA expression, HF-MSC were transduced with a tet-pLKO-puro lentivirus encoding for Tet repressor (TetR), selected with puromycin and expanded. These cells were then transduced with shLVDP encoding for shRNA against Rock1, Smad4 or Klf4 and coaxed to differentiate toward SMC lineage in the presence of DM. Three days later, Dox was applied to trigger shRNA expression and aSMA activity was measured as a function of time following addition of Dox. As expected, knockdown of genes that are important in SMC contractility decreased promoter activity as compared with control cells (scramble-shRNA) ( Figure 7) . Specifically, the level of aSMA activity was diminished within 12 h after the expression of Rock1 shRNA and decreased more slowly upon expression of Smad4 shRNA---down to 40% and 25% after 12 and 36 h, respectively. In contrast, Klf4 shRNA had no effect on aSMA promoter activity. These data demonstrated that shLVDP can capture the kinetics of promoter activity following Dox-inducible gene knockdown.
DISCUSSION
In this study, we sought to develop a strategy to monitor cellular activity in real time and at the same time examine how this activity is affected by certain genes or pathways. To this end, we generated a lentiviral vector with three transcriptional units to enable quantitative monitoring of gene expression with concomitant gene knockdown. Using this vector, we generated a lentiviral array, whereby each virus encoded for a different shRNA, and examined myogenic differentiation by monitoring aSMA promoter activity in response to gene knockdown. Our strategy yielded quantitative information of gene expression in human primary cells and stem cells, thereby providing a useful platform for deciphering gene regulatory networks of complex biological processes such as stem cell differentiation. Total fluorescent intensity of each spot on the array depends on the number of infected cells and the number of transgene copies per cell. These factors, however, might change significantly owing to variations in the viral titer making it difficult to obtain truly quantitative data. This may be particularly important for highthroughput experiments that require a large number of lentiviral vectors because it is very difficult to obtain lentivirus preparations of equal potency. As a result, the difference in signal intensity may reflect differences in gene transfer efficiency rather than the effect of gene knockdown. Although, in transfection methods co-transfection with a second plasmid constitutively encoding for a second reporter gene, for example, Renilla luc has been used for signal normalization, it is difficult to ensure similar transfection efficiency for both plasmids. In the present case, this strategy would be further complicated by the requirement for three plasmid co-transfection. On the other hand, expressing two genes and shRNA from the same vector provides an internal control for signal normalization enabling acquisition of quantitative data.
Indeed, our results showed that the novel shLVDP vector addressed this issue as the normalized fluorescence intensity (GFI/RFI) was independent of the gene transfer efficiency, for the range of viral titers tested in this study. Specifically, although increasing the viral titer increased the efficiency of gene knockdown as well as GFI and RFI, the normalized aSMA promoter activity (GFI/RFI) remained unaffected. As expected, knockdown of genes that promote contractility, for example, RhoA decreased normalized promoter activity significantly, whereas knockdown of myogenic GFI/RFI Figure 7 . Kinetics of aSMA promoter activity in response to Dox-induced gene knockdown. TetR expressing HF-MSCs were transduced with shLVDP vector encoding for Klf4, Smad4, Rock1 or scramble shRNA and coaxed to differentiate with TGF-b1 (10 ng ml --1 ). Three days later, Dox (10 mg ml --1 ) was added in the medium and the normalized aSMA promoter activity (GFI/RFI) was measured as a function of time using fluorescence microscopy.
inhibitors, fpr example, Klf4 increased promoter activity as compared with scramble control. However, in all cases the normalized activity remained independent of the efficiency of gene knockdown owing to variations in viral titer, suggesting that shLVDP enabled quantitative assessment of gene knockdown on the activity of a promoter that can be used to monitor a biological process, for example, stem cell differentiation.
We chose myogenic differentiation as an example to obtain proof-of-concept that the shLVDP can be used to examine how different pathways may affect MSC differentiation. To this end, we employed aSMA promoter as an indicator of myogenic phenotype 30 and selected several genes that are known to regulate contractile function, through the Rho or TGF-b1 pathways. In agreement with previous studies, 31, 32 TGF-b1 induced MSC differentiation toward the myogenic lineage as shown by enhanced aSMA promoter activity and verified at the protein level by western blot and immunostaining. Blocking TGF-b1 receptor activity or knocking down the TGF-b1 mediators Smad2, Smad3 or Smad4 significantly decreased aSMA activity. In addition, non-Smad pathways that are induced by TGF-b1 such as RhoA and its downstream effector Rock1 (refs 33,34) are important for myogenic differentiation. Similarly, MyoCD and myocardin related transcription factors, Mrtf-A and Mrtf-B are necessary for development of contractile phenotype through their role as SRF co-activators. 35 --38 As a result, knocking down any one of those factors severely impaired aSMA activity. On the other hand, knockdown of the MyoCD antagonist, Klf4 increased aSMA activity. 39 These results are in agreement with the literature and suggest that the normalized aSMA promoter activity accurately reflects the effect of well-known pathways on myogenic differentiation.
Surprisingly, we found that Smad7 knockdown had no significant effect in HASMC and BM-MSC but significantly decreased aSMA activity in HF-MSC, suggesting that Smad7 may differentially regulate myogenesis in different cell types. As inhibitor of Smad2/3, Smad7 is expected to decrease aSMA activity. However, Smad7 has also been implicated in myogenicpromoting pathways. For example, Smad3 was shown to interact with SRF, 40 whereas Smad7 activated the small GTPase Cdc42 41 and interacted with myocardin in the nucleus-promoting myogenesis. 42 Therefore, our results may suggest that in HASMCs and BM-MSCs, Smad7 may participate in both anti-and pro-myogenic interactions, so that their overall action balances out the influence of these pathways. On the other hand, in HF-MSC, SMAD7 may act predominantly in a pro-myogenic fashion, for example, by interacting with MyoCD, so that when it is knocked down, aSMA activity is reduced significantly. Although the mechanism remains elusive, our results suggest that gene knockdown with concomitant monitoring of promoter activity may reveal interesting differences between stem cells of different tissue origin as they differentiate along a common pathway.
The shLVDP can be adapted to a chemically-inducible shRNA expression system by introducing a second vector (tet-pLKO-puro) encoding for TetR, which binds to the TRE and inhibits shRNA expression. Upon addition of Dox, transcription is resumed as Dox binds to TetR releasing it from the promoter. 43 This system enables temporal control of shRNA expression at preferred times during the experiment, which is essential for studying genes that may have adverse effect on cell viability or other biological processes, for example, cytoskeletal re-organization. 44 For example, during myogenic differentiation, we observed a considerable level of cytotoxicity in cells actively expressing Rock1 shRNA (data not shown), making data interpretation difficult. Use of the inducible shLVDP enabled TGF-b1-induced differentiation before shRNA expression, thereby allowing us to assess the effect of Rock1 on aSMA promoter activity instead of viability. This system may be useful in tissue engineering where temporal control of shRNA expression may enable engineering of tissues lacking expression of genes that may be essential during a particular stage of tissue development.
For the inducible shRNA experiments, the cells were transduced with two lentiviruses: shLVDP and a virus encoding for TetR, raising the concern that any variability in the transduction efficiency of the TetR-encoding lentivirus might affect data normalization due to potential variability in shRNA induction. To minimize this possibility, HF-MSCs were first transduced with TetR lentivirus and selected with puromycin before they were transduced with the indicated shLVDP viruses. Most important, any variability in TetR concentration should be eliminated when the Dox concentration is high enough to block all the available repressor, thereby rendering shRNA induction solely dependent on the H1 promoter of the shLVDP vector. Indeed, preliminary experiments employing Smad4 shRNA showed that at 10 mg ml --1 of Dox the aSMA promoter response reached steady state, thereby suggesting that at that concentration Dox eliminated any variability in shRNA induction between cells (data not shown). For this reason, all experiments in this study were conducted with Dox at 10 mg ml --1 . The shLVDP vector may be ideal for generating shRNA libraries to discover new genes that are necessary for commitment of adult, embryonic or induced pluripotent stem cells to a particular lineage. Although several lentiviral constructs such as pLKO.1, pENTR or pLVTHM have been applied for generation of RNAi libraries, 8, 45, 46 the shLVDP provides a means for monitoring differentiation in real time, thereby facilitating selection of live cells. Moreover, by enabling quantitative activity measurements shLVDP libraries may enable development of quantitative criteria to evaluate the relative importance of different genes or pathways in stem cell differentiation and select cells that meet these criteria. This system would be useful in evaluating differentiation of embryonic or induced pluripotent stem cells, which are limited by low differentiation efficiency resulting in a heterogeneous mixture of differentiated, partially differentiated and undifferentiated cells.
In conclusion, the shLVDP lentivirus can be used to evaluate the effects of gene networks on complex biological processes such as stem cell differentiation, in live cells and in real time. Libraries of shLVDP vectors containing carefully selected transcription factorbinding sites (REs) and shRNAs may provide quantitative data that may be amenable to mathematical modeling for reverse engineering the gene networks controlling stem cell fate decisions or other complex biological processes.
MATERIALS AND METHODS
Cell culture
293T/17 cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle Medium (DMEM; GIBCO BRL, Grand Island, NY, USA) supplemented with 10% (v/v) fetal bovine serum (GIBCO) and 1% (v/v) antibiotic-antimycotic (GIBCO). BM-MSCs were purchased from Stem Cell Technologies (Vancouver, Canada) and HF-MSCs were isolated as described previously. 47, 48 Both cells were cultured in GM constituted of DMEM supplemented with 5% (v/v) fetal bovine serum and 1% (v/v) antibiotic-antimycotic and 1.0 ng ml --1 basic fibroblast growth factor (BD Biosciences, San Jose, CA, USA). The GM for HASMCs (GIBCO) constituted of 231 Medium (GIBCO) that was supplemented with smooth muscle growth supplement (SMGS; GIBCO).
Lentiviral vector construction strategy and lentiviral vector preparation
The lentiviral vectors used in this study were generated as follows. First, we used the shRNA cassette from pLVTHM (Addgene, Cambridge, MA, USA), which encodes for shRNA under the Dox-regulatable H1 promoter between MluI and ClaI restriction sites in the 3 0 LTR of the vector. An EcoRV site was added immediately downstream of MluI for subsequent cloning. Afterwards, the 3 0 LTR of pLVTHM was amplified by PCR with primers THM-for: 5 0 -TCTTCCGCGTCTTCGCCTTC-3 0 and THM-rev: 5 0 -AATTCT AGATGCTGCTAGAG-3 0 . The PCR product was used to replace the 3 0 LTR in the pCSCG (Addgene) between the KpnI and PmeI sites. The resulting vector was digested with PpuMI and Bsu36I to remove CMV-GFP and replace it with the dual promoter cassettes: sMAR8_TKpA_DRE2_CMV_ cHS4_Tactb_SPA_EGFP_hPGK, or sMAR8_TKpA_DRE2_hPGK_cHS4_Tactb_ SPA_ZsG-DR_MCS from our previously reported LVDP vectors in which DsRed2 was replaced by DsRed-Express2 (Clontech, Mountain View, CA, USA). These sequences were cloned in trans to the viral LTRs to avoid premature termination of viral mRNA by the inserted polyAs during virus production in packaging cells as reported previously. 22 The resulting shRNA encoding LentiViral Dual Promoter vectors were termed shLVDP vectors.
shRNAs were cloned into this vector between the EcoRV and ClaI sites immediately downstream of the H1 promoter in the 3 0 LTR. Briefly, the two complementary oligos for each shRNA were mixed at 1:1 ratio to a final concentration of 50 mM and annealed under the following conditions: 951C for 30 s, 721C for 2 min, 37 1C for 2 min and 25 1C for 2 min. All cloned sequences were confirmed by sequencing with ABI PRISM 3130XL Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). All siRNA sequences are listed in Table 1 .
Finally, the aSMA promoter sequence was cloned into the multiple cloning site (MCS) to drive ZsG-DR expression. To this end, the promoter was amplified from human genomic DNA by PCR with primers: hACTA2F: 5 0 -ACAACAGTTAACCTTCCTGTCAAGGAGGTTAG-3 0 and hACTA2R: 5 0 -ACAAC AACCGGTCGGGTAATTAAAAGAGCCAC-3 0 . Phusion High-Fidelity DNA Polymerase (New England Biolabs, Ipswich, MA, USA) was used for PCR according to the manufacturer's protocol and the PCR product was ligated into the MCS between the HpaI and AgeI sites.
For lentivirus production, 293T/17 cells were transfected with three plasmids: (16.8 mg each lentiviral vector, 15 mg psPAX2, and 5 mg pMD.G), using the standard calcium phosphate precipitation method. Virus was harvested 24 h post transfection, filtered through 0.45 mm filter (Millipore, Bedford, MA, USA), pelleted by ultracentrifugation (50 000 g at 4 1C for 2 h) and resuspended in fresh medium. The virus titer was determined using HASMCs cells and was used for subsequent experiments at an MOIB5.
Infection and differentiation protocol
HASMCs (12 000 cells per well), BM-MSCs (12 000 cells per well) or HF-MSC (4000 cells per well) were plated in 96-well tissue culture treated plates (NUNC, Rochester, NY, USA). The cells were transduced with different viruses carrying different shRNAs in the presence of 8 mg ml --1 polybrene under GM. Viruses were removed 2 h after infection and fresh cell culture medium was added. After 3 days, the cells were induced to differentiate by treatment with 231 medium supplemented with SMDS (GIBCO), 5% (v/v) fetal bovine serum and 10 ng ml --1 TGF-b1 (Biolegends, San Diego, CA, USA), (DM). DM for BM-MSCs or HF-MSCs constituted of DMEM containing 5% (v/v) fetal bovine serum, 30 mg ml --1 heparin (App Pharmaceuticals, Schaumburg, IL, USA) and 10 ng ml --1 TGF-b1. After 3 days, the cells were imaged and 2 days later they were procesed for flow cytometry as described previously. 22 Cell transfection and gene knockdown 293T cells (8 Â 10 5 per well) were seeded in 6-well tissue culture-treated plates and transfection was done using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), following the manufacturer's instructions. Transfection was performed for 24 h and cells were replenished with fresh medium. The cells were cultured for 3 days and gene-knockdown efficiency was assessed by qRT-PCR. Briefly, total mRNA was isolated from the cells with RNeasy Mini Kit (Qiagen, Valencia, CA, USA) and cDNA was synthesized from the isolated mRNA using Superscript III cDNA Synthesis Kit (Invitrogen). The cDNA was subjected to real-time PCR using SYBR Green Kit (Bio-Rad, Hercules, CA, USA). Primers for real-time PCR were listed in Table 2 .
Immunostaining
Transduced HAMCS cells were cultured in DM for 3 days. Afterwards, the cells were washed three times with phosphate-buffered saline (PBS), and fixed in a mixture of methanol and acetone (75:25, v/v) for 10 min at room temperature (RT). After fixation, the cells were washed with PBS twice and permeabilized with 0.1% (v/v) Triton X 100 in PBS for 10 min at RT. Afterwards, the cells were blocked with 0.01% (v/v) Triton X 100 and 1% (w/v) bovine serum albumin (EMD Chemicals, San Diego, CA, USA) in PBS for 1 h at RT. Thereafter, the cells were incubated with primary antibody (1:50 dilution, mouse anti-human aSMA; Serotec, Raleigh, NC, USA) in blocking buffer overnight at 4 1C. The cells were washed for three times with PBS and Alexa 488-conjugated goat-anti-mouse IgG (20 mg ml --1 , Molecular Probes, Grand Island, NY, USA) in blocking buffer was applied for 1 h at RT. The cells were washed three times with PBS and the cell nuclei were counterstained with Hoechst 33258 (25 mg ml --1 in TNE buffer: 10 mmol l --1 Tris, 2 mol l --1 NaCl, 1 mmol l --1 EDTA, pH 7.4; Molecular Probes) for 10 min at RT. Finally, the cells were washed for three times and fluorescent images were obtained using an inverted fluorescence microscope Zeiss Observer.Z1.
Compaction of fibrin hydrogels
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